Mohamed Ali

No ORCID on file · 24 papers in corpus · active 2017-2026

Study types

  • article 7
  • review 4
  • other 2
  • preprint 1

Condition tags

  • endometriosis 5
  • infertility 4
  • dysmenorrhea 3
  • adenomyosis 1
other 2026
Environmental toxicology ·doi:10.1002/tox.70046

This study investigates how phthalate exposure contributes to uterine fibroid (UF) development by studying the effects of the Mono-(2-ethyl-5-hydroxyhexyl) phthalate (MEHHP), a metabolite of Di(2-ethylhexyl) phthalate, on myometrial stem ce…

2025
Bioscience of microbiota, food and health ·doi:10.12938/bmfh.2024-129

Dysmenorrhea, the most prevalent gynecologic complaint among adolescent females, often has unclear underlying causes. However, it is widely recognized that the accumulation of estrogen and prostaglandins mediates inflammatory responses, lea…

article 2025
Biomedicines ·doi:10.3390/biomedicines13081970

Background: Uterine leiomyomas, commonly known as fibroids, are the most prevalent benign tumors in women of reproductive age and a major contributor to gynecological morbidity. Although surgery and hormonal therapies are standard treatment…

other 2025
Cell proliferation ·doi:10.1111/cpr.70025

Uterine fibroids (UFs) are the most common benign gynecologic tumours affecting women of reproductive age. This study aims to deepen the understanding of UFs complex aetiology through harnessing the power of 3D organoid models derived from …

review 2024
Nutrients ·doi:10.3390/nu16040559

The most common malignant gynecologic diseases are cervical, uterine, ovarian, vaginal, and vulvar cancer. Among them, ovarian cancer causes more deaths than any other cancer of the female reproductive system. A great number of women suffer…

2024
Nutrients ·doi:10.3390/nu16234026

BackgroundPrimary dysmenorrhea, a highly prevalent condition that significantly impacts women's daily activities and quality of life, occurs without underlying pelvic pathological changes. Conventional treatments, such as warm water therapy…

article 2024
·doi:10.1016/j.redox.2024.103411

Uterine leiomyoma (UL), commonly referred to as benign tumors, is characterized by excessive cell proliferation, extracellular matrix (ECM) accumulation, and the presence of stem cell-like properties. Nicotinamide adenine dinucleotide (NAD …

preprint 2024
·doi:10.2139/ssrn.4845152
article 2023
·doi:10.3390/ijms241411641

The period during which tissue and organ development occurs is particularly vulnerable to the influence of environmental exposures. However, the specific mechanisms through which biological pathways are disrupted in response to developmenta…

2023
International journal of molecular sciences ·doi:10.3390/ijms242115972

Uterine fibroids (UFs) are common tumors in women of reproductive age. It is imperative to comprehend UFs' associated risk factors to facilitate early detection and prevention. Simple relying on surgical/pharmacological treatment of advance…

article 2023
Journal of endometriosis and uterine disorders ·doi:10.1016/j.jeud.2023.100018

• Uterine fibroids are the most common benign tumor to women of reproductive age with no clear pathomechanism. • Current medical therapies are designed to blunt the stimulatory effects of gonadal steroid hormones on uterine fibroids growth.…

2023
Cells ·doi:10.3390/cells12081117

Uterine fibroids (UFs) are the most important benign neoplastic threat to women's health worldwide, with a prevalence of up to 80% in premenopausal women, and can cause heavy menstrual bleeding, pain, and infertility. Progesterone signaling…

2022
Expert opinion on pharmacotherapy ·doi:10.1080/14656566.2022.2030705

IntroductionUterine Fibroids (UFs) are the most predominant benign tumor in women who are coming of reproductive age, and causes intense economic load priced in billions of US dollars. Historically, surgery has been the main definitive trea…

2022
Endocrine reviews ·doi:10.1210/endrev/bnab039

Uterine fibroids are benign monoclonal neoplasms of the myometrium, representing the most common tumors in women worldwide. To date, no long-term or noninvasive treatment option exists for hormone-dependent uterine fibroids, due to the limi…

2022
Expert opinion on drug safety ·doi:10.1080/14740338.2022.1989409

IntroductionUterine fibroids (UFs) are the most prevalent benign neoplastic threat originating from myometria of reproductive age women, with a profound financial load valued in hundreds of billions of dollars. Unfortunately, there is no cu…

review 2022
International journal of molecular sciences ·doi:10.3390/ijms23052720

Uterine fibroids (UFs) are monoclonal, benign tumors that contain abnormal smooth muscle cells and the accumulation of extracellular matrix (ECM). Although benign, UFs are a major source of gynecologic and reproductive dysfunction, ranging …

article 2021
·doi:10.1016/j.fertnstert.2021.07.855
review 2021
Expert review of clinical pharmacology ·doi:10.1080/17512433.2021.1900726

INTRODUCTION: Uterine fibroids (UFs) are the most common benign tumor arising from myometrium of reproductive age women, with significant financial burden estimated in hundreds of billions of dollars. Unfortunately, there are limitations in…

review 2021
Nutrients ·doi:10.3390/nu13041178

Diet and nutrition are fundamental in maintaining the general health of populations, including women's health. Health status can be affected by nutrient deficiency and vice versa. Gene-nutrient interactions are important contributors to hea…

2020
The Journal of clinical endocrinology and metabolism ·doi:10.1210/clinem/dgz227

ContextUterine fibroids (UF) are the most common benign tumor of the myometrium (MM) in women of reproductive age. However, the mechanism underlying the pathogenesis of UF is largely unknown.ObjectiveTo explore the link between nuclear β-ca…

article 2020
·doi:10.1210/jendso/bvaa046.668

Abstract Endometriosis and uterine fibroids (leiomyomas) are benign gynecological disorders affecting 5-15% of women of reproductive age. They cause a wide range of symptoms including mild to severe pelvic pain and infertility. Due to a pau…

2020
Menopause (New York, N.Y.) ·doi:10.1097/gme.0000000000001438

Uterine fibroids (UFs) are benign tumors that arise from a single genetically altered mesenchymal stem cell under the influence of gonadal hormones. UFs are the most common benign gynecologic tumors in premenopausal women worldwide. It is e…

article 2019
·doi:10.1358/dof.2019.44.2.2927590
2017
Biology of reproduction ·doi:10.1093/biolre/iox094

Uterine fibroids (UFs, AKA leiomyoma) are the most important benign neoplastic threat to women's health, with costs up to hundreds of billions of health care dollars worldwide. Uterine fibroids caused morbidities exert a tremendous health t…